Cargando…

Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?

INTRODUCTION: Prediction of optimal cytoreduction in patients with advanced epithelial ovarian caner preoperatively. METHODS: Patients with advanced epithelial ovarian cancer who underwent surgery for the first time from Jan. to June 2008 at gynecologic oncology ward of TUMS (Tehran University of Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousavi, Azam-Sadat, Mazhari, Marjan Moradi, Guilani, Mitra Modares, Ghaemmaghami, Fatemeh, Behtash, Nadereh, Akhavan, Setareh
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844392/
https://www.ncbi.nlm.nih.gov/pubmed/20170515
http://dx.doi.org/10.1186/1477-7819-8-11
_version_ 1782179301107433472
author Mousavi, Azam-Sadat
Mazhari, Marjan Moradi
Guilani, Mitra Modares
Ghaemmaghami, Fatemeh
Behtash, Nadereh
Akhavan, Setareh
author_facet Mousavi, Azam-Sadat
Mazhari, Marjan Moradi
Guilani, Mitra Modares
Ghaemmaghami, Fatemeh
Behtash, Nadereh
Akhavan, Setareh
author_sort Mousavi, Azam-Sadat
collection PubMed
description INTRODUCTION: Prediction of optimal cytoreduction in patients with advanced epithelial ovarian caner preoperatively. METHODS: Patients with advanced epithelial ovarian cancer who underwent surgery for the first time from Jan. to June 2008 at gynecologic oncology ward of TUMS (Tehran University of Medical Sciences) were eligible for this study. The possibility of predicting primary optimal cytoreduction considering multiple variables was evaluated. Variables were peritoneal carcinomatosis, serum CA125, ascites, pleural effusion, physical status and imaging findings. Univariate comparisons of patients underwent suboptimal cytoreduction carried out using Fisher's exact test for each of the potential predictors. The wilcoxon rank sum test was used to compare variables between patients with optimal versus suboptimal cytoreduction. RESULTS: 41 patients met study inclusion criteria. Statistically significant association was noted between peritoneal carcinomatosis and suboptimal cytoreduction. There were no statistically significant differences between physical status, pleural effusion, imaging findings, serum CA125 and ascites of individuals with optimal cytoreduction compared to those with suboptimal cytoreduction. CONCLUSIONS: Because of small populations in our study the results are not reproducible in alternate populations. Only the patient who is most unlikely to undergo optimal cytoreduction should be offered neoadjuvant chemotherapy, unless her medical condition renders her unsuitable for primary surgery.
format Text
id pubmed-2844392
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28443922010-03-24 Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively? Mousavi, Azam-Sadat Mazhari, Marjan Moradi Guilani, Mitra Modares Ghaemmaghami, Fatemeh Behtash, Nadereh Akhavan, Setareh World J Surg Oncol Research INTRODUCTION: Prediction of optimal cytoreduction in patients with advanced epithelial ovarian caner preoperatively. METHODS: Patients with advanced epithelial ovarian cancer who underwent surgery for the first time from Jan. to June 2008 at gynecologic oncology ward of TUMS (Tehran University of Medical Sciences) were eligible for this study. The possibility of predicting primary optimal cytoreduction considering multiple variables was evaluated. Variables were peritoneal carcinomatosis, serum CA125, ascites, pleural effusion, physical status and imaging findings. Univariate comparisons of patients underwent suboptimal cytoreduction carried out using Fisher's exact test for each of the potential predictors. The wilcoxon rank sum test was used to compare variables between patients with optimal versus suboptimal cytoreduction. RESULTS: 41 patients met study inclusion criteria. Statistically significant association was noted between peritoneal carcinomatosis and suboptimal cytoreduction. There were no statistically significant differences between physical status, pleural effusion, imaging findings, serum CA125 and ascites of individuals with optimal cytoreduction compared to those with suboptimal cytoreduction. CONCLUSIONS: Because of small populations in our study the results are not reproducible in alternate populations. Only the patient who is most unlikely to undergo optimal cytoreduction should be offered neoadjuvant chemotherapy, unless her medical condition renders her unsuitable for primary surgery. BioMed Central 2010-02-19 /pmc/articles/PMC2844392/ /pubmed/20170515 http://dx.doi.org/10.1186/1477-7819-8-11 Text en Copyright ©2010 Mousavi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Mousavi, Azam-Sadat
Mazhari, Marjan Moradi
Guilani, Mitra Modares
Ghaemmaghami, Fatemeh
Behtash, Nadereh
Akhavan, Setareh
Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?
title Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?
title_full Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?
title_fullStr Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?
title_full_unstemmed Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?
title_short Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?
title_sort can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844392/
https://www.ncbi.nlm.nih.gov/pubmed/20170515
http://dx.doi.org/10.1186/1477-7819-8-11
work_keys_str_mv AT mousaviazamsadat canprimaryoptimalcytoreductionbepredictedinadvancedepithelialovariancancerpreoperatively
AT mazharimarjanmoradi canprimaryoptimalcytoreductionbepredictedinadvancedepithelialovariancancerpreoperatively
AT guilanimitramodares canprimaryoptimalcytoreductionbepredictedinadvancedepithelialovariancancerpreoperatively
AT ghaemmaghamifatemeh canprimaryoptimalcytoreductionbepredictedinadvancedepithelialovariancancerpreoperatively
AT behtashnadereh canprimaryoptimalcytoreductionbepredictedinadvancedepithelialovariancancerpreoperatively
AT akhavansetareh canprimaryoptimalcytoreductionbepredictedinadvancedepithelialovariancancerpreoperatively